SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193805-21-000923
Filing Date
2021-06-22
Accepted
2021-06-22 16:31:06
Documents
12
Period of Report
2021-06-18
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 e620743_8k-at.htm   iXBRL 8-K 31508
  Complete submission text file 0001193805-21-000923.txt   203791

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA arct-20210618.xsd EX-101.SCH 3029
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE arct-20210618_lab.xml EX-101.LAB 34238
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arct-20210618_pre.xml EX-101.PRE 22361
5 EXTRACTED XBRL INSTANCE DOCUMENT e620743_8k-at_htm.xml XML 3626
Mailing Address 10628 SCIENCE CENTER DRIVE SUITE 250 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE SUITE 250 SAN DIEGO CA 92121 8589002660
Arcturus Therapeutics Holdings Inc. (Filer) CIK: 0001768224 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38942 | Film No.: 211035708
SIC: 2834 Pharmaceutical Preparations